Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP) Share Price

Price 9.75p on 28-05-2025 at 17:21:41
Change 0.00p 0%
Buy 10.00p
Sell 9.50p
Buy / Sell SCLP Shares
Last Trade: Sell 10,000.00 at 9.60p
Day's Volume: 173,811
Last Close: 9.75p
Open: 9.75p
ISIN: GB00B63D3314
Day's Range 9.75p - 9.75p
52wk Range: 7.25p - 19.50p
Market Capitalisation: £101m
VWAP: 9.758569p
Shares in Issue: 1,037m

Scancell Holdings (SCLP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 10,000 9.60p Ordinary
15:20:32 - 28-May-25
Sell* 50,000 9.605p Ordinary
14:46:53 - 28-May-25
Buy* 30 9.92p Ordinary
13:38:37 - 28-May-25
Buy* 201 9.92p Ordinary
13:21:43 - 28-May-25
Sell* 15,659 9.605p Ordinary
13:18:36 - 28-May-25
Sell* 4,625 9.605p Ordinary
13:10:47 - 28-May-25
Sell* 10,565 9.6278p Ordinary
11:07:59 - 28-May-25
Buy* 50 9.92p Ordinary
09:32:26 - 28-May-25
Buy* 1,000 9.92p Ordinary
09:13:29 - 28-May-25
Sell* 100 9.50p SI Trade
08:00:56 - 28-May-25
See more Scancell Holdings trades

Scancell Holdings (SCLP) Share Price History

Time period:
to
Date Open High Low Close Volume
28th May 2025 (Wed) 9.75 9.75 9.75 9.75 173,811
27th May 2025 (Tue) 9.75 9.75 9.75 9.75 227,290
26th May 2025 (Mon) 9.90 9.90 9.90 9.90 0
23rd May 2025 (Fri) 10.00 9.90 9.90 9.90 467,133
22nd May 2025 (Thu) 10.00 10.00 10.00 10.00 48,358
21st May 2025 (Wed) 9.50 10.25 9.50 10.00 960,551
20th May 2025 (Tue) 9.25 9.25 9.25 9.25 303,548
19th May 2025 (Mon) 9.25 9.25 9.25 9.25 498,321
16th May 2025 (Fri) 9.25 9.25 9.25 9.25 479,015
15th May 2025 (Thu) 9.10 9.25 9.10 9.25 119,982
14th May 2025 (Wed) 9.25 9.25 8.85 9.10 295,489
13th May 2025 (Tue) 9.50 9.66 9.25 9.25 186,888
12th May 2025 (Mon) 10.00 10.00 9.50 9.50 307,053
9th May 2025 (Fri) 9.50 10.00 9.50 10.00 252,103
8th May 2025 (Thu) 9.75 10.00 9.75 10.00 248,435
7th May 2025 (Wed) 10.05 10.05 9.75 9.75 211,197
6th May 2025 (Tue) 10.25 10.25 10.05 10.05 218,170
5th May 2025 (Mon) 10.425 10.425 10.425 10.425 0
2nd May 2025 (Fri) 10.25 10.25 10.25 10.25 172,214
1st May 2025 (Thu) 10.25 10.25 10.25 10.25 146,309
30th Apr 2025 (Wed) 10.75 10.75 10.50 10.75 867,350
29th Apr 2025 (Tue) 11.25 11.25 10.25 10.75 2,086,063
See more Scancell Holdings price history

Scancell Holdings (SCLP) Regulatory News

Date Source Headline
21st May 2025 7:00 am RNS Director Dealing
14th Apr 2025 7:00 am RNS Partnership with NHS Cancer Vaccine Launch Pad
1st Apr 2025 7:00 am RNS Scancell to present at 2025 AACR Annual Meeting
20th Feb 2025 7:00 am RNS Issue of share options
17th Feb 2025 7:00 am RNS Scancell presenting at AACR IO conference
30th Jan 2025 7:00 am RNS Interim Results
23rd Jan 2025 7:00 am RNS Notice of Interim Results
9th Jan 2025 7:00 am RNS Modi-1 Vaccine Achieves Early Clinical Validation
9th Dec 2024 11:41 am RNS Result of Retail Offer and Total Voting Rights
5th Dec 2024 12:39 pm RNS Result of Placing and Subscription
See more Scancell Holdings regulatory news

Scancell Holdings (SCLP) Share News

Scancell partners with NHS to fast-track melanoma vaccine trial

14th Apr 2025 14:02

(Alliance News) - Scancell Holdings PLC on Monday said it has partnered with the NHS Cancer Vaccine Launch Pad, to accelerate patient recruitment into the fourth cohort of its phase 2 scope study for a targeted melanoma vaccine. Read More

LONDON MARKET MIDDAY: Stocks up, China warns on British Steel dispute

14th Apr 2025 11:47

(Alliance News) - Stock prices in London were in the green at midday on Monday, while Beijing has warned the UK against "politicising" an unfolding spat over the future of Chinese-owned British Steel. Read More

AIM WINNERS & LOSERS: Scancell in partnership with NHS 'Launch Pad'

14th Apr 2025 10:08

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

IN BRIEF: Scancell hurt by revaluation of derivative liability loss

30th Jan 2025 19:54

Scancell Holdings PLC - Oxford, UK-based pharmaceutical firm - Pretax loss multiplies to GBP13.8 million in the six months to October 31 from GBP3.6 million a year prior. R&D expenses rise to GBP8.0 million from GBP5.7 million, administrative expenses edge up to GBP2.5 million from GBP2.4 million. Bottom line hit by GBP4.5 million loss relating to revaluation of derivative liability compared to GBP4.9 million gain a year prior. Cash balances at October 31 are GBP9.1 million compared to GBP14.8 million at April 30, 2024. Sees cash runway to the second half of 2026 beyond multiple clinical milestones. Read More

UK earnings, trading statements calendar - next 7 days

23rd Jan 2025 17:08

Read More

See more Scancell Holdings news
FTSE 100 Latest
Value8,726.01
Change-52.04

Login to your account

Forgot Password?

Not Registered